Laboratorio Farmaceutico Erfo S.p.A. (BIT: ERFO)

Market Cap	11.10M
Revenue (ttm)	5.82M
Net Income (ttm)	441.11K
Shares Out	8.54M
EPS (ttm)	0.05
PE Ratio	25.16
Forward PE	21.67
Dividend	0.06 (4.30%)
Ex-Dividend Date	n/a

Volume	9,000
Average Volume	64,250
Open	1.400
Previous Close	1.400
Day's Range	1.365 - 1.400
52-Week Range	0.880 - 1.500
Beta	1.34
RSI	68.26
Earnings Date	Jan 10, 2025

About BIT: ERFO

Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and packaging services. The company was founded in 2013 and is based in Villafranca Tirrena, Italy.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2013
• Employees: 33
• Stock Exchange: Borsa Italiana
• Ticker Symbol: ERFO

Financial Performance

In 2023, ERFO's revenue was 5.93 million, an increase of 25.70% compared to the previous year's 4.72 million. Earnings were 590,331, a decrease of -17.56%.